CA2131315A1 - Methode peroperatoire de detection et de localisation des tissus tumoraux - Google Patents

Methode peroperatoire de detection et de localisation des tissus tumoraux

Info

Publication number
CA2131315A1
CA2131315A1 CA002131315A CA2131315A CA2131315A1 CA 2131315 A1 CA2131315 A1 CA 2131315A1 CA 002131315 A CA002131315 A CA 002131315A CA 2131315 A CA2131315 A CA 2131315A CA 2131315 A1 CA2131315 A1 CA 2131315A1
Authority
CA
Canada
Prior art keywords
group
peptide
peptide compound
labelled
radionuclide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002131315A
Other languages
English (en)
Inventor
Geert J. Ensing
Karel J. Panek
Bareld J. Doedens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2131315A1 publication Critical patent/CA2131315A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA002131315A 1992-03-25 1993-03-24 Methode peroperatoire de detection et de localisation des tissus tumoraux Abandoned CA2131315A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92200848 1992-03-25
EP92200848.7 1992-03-25

Publications (1)

Publication Number Publication Date
CA2131315A1 true CA2131315A1 (fr) 1993-09-30

Family

ID=8210503

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002131315A Abandoned CA2131315A1 (fr) 1992-03-25 1993-03-24 Methode peroperatoire de detection et de localisation des tissus tumoraux

Country Status (5)

Country Link
EP (1) EP0636032A1 (fr)
JP (1) JPH07505621A (fr)
AU (1) AU3967593A (fr)
CA (1) CA2131315A1 (fr)
WO (1) WO1993018797A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2183421A1 (fr) * 1994-02-18 1995-08-24 John Mertens Composes peptidiques marques
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
AUPO066096A0 (en) * 1996-06-26 1996-07-18 Peptide Delivery Systems Pty Ltd Oral delivery of peptides
WO1998033531A1 (fr) * 1997-02-03 1998-08-06 Mallinckrodt Medical, Inc. Procede servant a detecter et a localiser des tumeurs malignes humaines
CA2341489A1 (fr) * 1998-09-25 2000-04-06 Mallinckrodt, Inc. Radioligand recepteur de la somatostatine, a absorption amelioree
US6331703B1 (en) 1999-03-12 2001-12-18 Ethicon Endo-Surgery, Inc. Guidance method for radiation detection
US6167297A (en) * 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
CA2525574C (fr) 2003-05-15 2015-06-30 Trustees Of Tufts College Agents therapeutiques comprenant des analogues stables de peptides et de polypeptides
US7968080B2 (en) 2003-08-20 2011-06-28 The Regents Of The University Of California Somatostatin analogs with inhibitory activity to growth hormone release
CA2621699A1 (fr) 2005-09-08 2007-03-15 Trustees Of Tufts College Analogues de glp-1 stabilises

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
EP0436005B1 (fr) * 1989-07-20 1995-03-29 Sandoz Ltd. Derives de polypeptide etiquetes

Also Published As

Publication number Publication date
EP0636032A1 (fr) 1995-02-01
AU3967593A (en) 1993-10-21
WO1993018797A1 (fr) 1993-09-30
JPH07505621A (ja) 1995-06-22

Similar Documents

Publication Publication Date Title
EP0804252B1 (fr) Agents chelateurs metalliques renfermant thiol, diamide et monoamine
CN101648028B (zh) 维生素-定向的显象剂
EP0759786B1 (fr) Conjugues peptide-chelate metallique se liant a la somatostatine
USRE37710E1 (en) Radiometal-binding analogues of luteinizing hormone releasing hormone
Wraight et al. The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma
EP0831938B1 (fr) Compositions de peptides radiomarques pour le ciblage specifique d'un site
HU211468A9 (en) Detectable somatostatin analogues containing a chelating group
EP3375787B1 (fr) Dérivé peptidique de thio-urée, composé marqué par un radio-isotope le contenant et composition pharmaceutique le contenant en tant que principe actif pour le traitement ou le diagnostic du cancer de la prostate
US20020155064A1 (en) Method for detection and localization of malignant human tumours
JP2014515729A (ja) 新規ｐｅｔトレーサー
AU657770B2 (en) Radiolabelled somatostatin derivatives, their preparation and use
EP0719790B1 (fr) Peptides chélatants des ions métalliques et leurs utilisation
CA2131315A1 (fr) Methode peroperatoire de detection et de localisation des tissus tumoraux
CN110496233B (zh) 一种spect显像剂及其标记前体及其制备方法、组合物和用途
US7122622B2 (en) Peptide compounds having improved binding affinity to somatostatin receptors
EP0584256B1 (fr) Composes et compositions pour la detection et la loclisation de tissus comprenant des recepteurs de neurokinine 1
US11167048B2 (en) Dual targeting ligand for cancer diagnosis and treatment
EP0857071A1 (fr) Composes de biotine (radio) marques
US6455025B1 (en) Polysaccharide-peptide derivatives
US20040185510A1 (en) Use of labelled CCK-B receptor ligands for the detection and localization of malignant human tumours
EP2695891B1 (fr) Octapeptide, radiopharmaceutique sur la base de celui-ci et procédé de diagnostic de tumeurs
Fedotova et al. [161Tb] Tb-Thz-Phe-D-Trp-Lys-Thr-DOTA: A potential radiopharmaceutical for the treatment of neuroendocrine tumors
WO2023008556A1 (fr) Composé radiomarqué et son utilisation
US20070041903A1 (en) Modified minigastrin analogs for oncology applications
EP1501554B1 (fr) Derives benzothienyle de la somatostatine, selectifs pour certains recepteurs de la somatostatine

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20010326